MRD dynamics during maintenance for improved prognostication of 1280 myeloma patients in TOURMALINE-MM3 and -MM4 trials.
暂无分享，去创建一个
K. Suryanarayan | M. Dimopoulos | B. Paiva | M. Mateos | M. Cavo | C. Min | S. Zweegman | I. Špička | I. Manrique | N. Giuliani | Jose Estevam | W. Fu | A. Dash | R. Teipel | R. Labotka | Christine Rojas | A. Vorog | Cong Li | F. Gay | Bingxia Wang